175 related articles for article (PubMed ID: 9854997)
1. Molecular analysis of lacI mutants from transgenic fibroblasts exposed to 1,2-epoxybutene.
Saranko CJ; Pluta LJ; Recio L
Carcinogenesis; 1998 Nov; 19(11):1879-87. PubMed ID: 9854997
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
3. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
4. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
5. The butadiene metabolite, 1,2:3,4-diepoxybutane, induces micronuclei but is only weakly mutagenic at lacI in the Big Blue Rat2 lacI transgenic cell line.
Saranko CJ; Recio L
Environ Mol Mutagen; 1998; 31(1):32-40. PubMed ID: 9464313
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity and mutational spectra of 1,3-butadiene in the bone marrow of B6C3F1 lacI transgenic mice.
Recio L; Sisk S; Meyer K; Pluta L; Bond JA
Toxicology; 1996 Oct; 113(1-3):106-11. PubMed ID: 8901889
[TBL] [Abstract][Full Text] [Related]
7. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
Recio L; Pluta LJ; Meyer KG
Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
[TBL] [Abstract][Full Text] [Related]
8. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacI transgenic mice exposed to 1,3-butadiene.
Recio L; Meyer KG
Environ Mol Mutagen; 1995; 26(1):1-8. PubMed ID: 7641703
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene.
Sisk SC; Pluta LJ; Bond JA; Recio L
Carcinogenesis; 1994 Mar; 15(3):471-7. PubMed ID: 8118931
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice.
Cochrane JE; Skopek TR
Carcinogenesis; 1994 Apr; 15(4):719-23. PubMed ID: 8149486
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
[TBL] [Abstract][Full Text] [Related]
15. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats.
Chen T; Aidoo A; Manjanatha MG; Mittelstaedt RA; Shelton SD; Lyn-Cook LE; Casciano DA; Heflich RH
Mutat Res; 1998 Jul; 403(1-2):199-214. PubMed ID: 9726020
[TBL] [Abstract][Full Text] [Related]
17. Mutation spectrum of 4-nitroquinoline N-oxide in the lacI transgenic Big Blue Rat2 cell line.
Ryu J; Youn J; Kim Y; Kwon O; Song Y; Kim H; Cho K; Chang I
Mutat Res; 1999 Sep; 445(1):127-35. PubMed ID: 10521698
[TBL] [Abstract][Full Text] [Related]
18. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane.
Steen AM; Meyer KG; Recio L
Mutagenesis; 1997 Mar; 12(2):61-7. PubMed ID: 9106245
[TBL] [Abstract][Full Text] [Related]
19. In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide.
Recio L; Donner M; Abernethy D; Pluta L; Steen AM; Wong BA; James A; Preston RJ
Mutagenesis; 2004 May; 19(3):215-22. PubMed ID: 15123787
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of lacI mutations in Rat2 cells exposed to 7,12-dimethylbenz[a]anthracene: evidence for DNA sequence and DNA strand biases for mutation.
Manjanatha MG; Chen JB; Shaddock JG; Harris AJ; Shelton SD; Casciano DA
Mutat Res; 1996 Nov; 372(1):53-64. PubMed ID: 9003531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
